Investing

Arvinas : ARVN

ARVN

Stock Data

$10.51

$0.61 (6.16%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Arvinas Inc is a pioneering biotech firm focused on developing innovative treatments by targeting disease-causing proteins for degradation. Utilizing its proprietary PROTAC technology, Arvinas is advancing a novel class of therapies, including potential treatments for prostate cancer and breast cancer. With ongoing clinical trials and strategic partnerships with major pharmaceutical companies, Arvinas is at the forefront of leveraging the body's natural processes to fight serious diseases. Founded in 2013, the company is headquartered in New Haven, Connecticut, marking a significant player in the biotechnology industry.

All Arvinas Articles

5 Articles

Trey Thoelcke | Aug 6, 2024 at 9:15 AM EDT

Prediction: This Pharma Stock Will Be the Best Performer the Rest of 2024

Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big…

Lee Jackson | Nov 25, 2022 at 10:28 AM EST

Friday’s Top Analyst Upgrades and Downgrades: Analog Devices, Autodesk, Beyond Meat, CVS Health, Dick’s Sporting Goods, Medtronic, Riot Blockchain, Tesla, Yum! Brands and More

Here are the top analysts calls for Friday, November 25.

Lee Jackson | Oct 18, 2022 at 8:53 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Apple, Citigroup, JPMorgan, Kroger, Livent, Salesforce, SunPower and More

Tuesday's top analyst upgrades and downgrades included Apple, Chipotle Mexican Grill, Citigroup, Constellation Energy, Fastenal, JPMorgan Chase, Kroger, Livent, News…

Lee Jackson | Sep 27, 2022 at 8:50 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Bristol-Myers, Costco, Exxon, FedEx, Lucid, Medtronic, Micron Technology, Salesforce, Six Flags, Unity Software and More

Tuesday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Costco Wholesale, Dollar General, Exxon Mobil, FedEx, Horizon Therapeutics, Hyatt Hotels,…

Chris Lange | May 9, 2022 at 2:28 PM EDT

From Bad to Worse and Then Some: Analysts Upgrade or Downgrade Domino’s, iHeartMedia, Match Group, Virgin Galactic and More

Monday’s additional top analyst upgrades and downgrades were on Domino’s, iHeartMedia, Match Group, Virgin Galactic and more.